Exact Mass: 337.0586346

Exact Mass Matches: 337.0586346

Found 32 metabolites which its exact mass value is equals to given mass value 337.0586346, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

5-Hydroxymethyldeoxycytidylate

5-Hydroxymethyldeoxycytidylate; 5-Hydroxymethyldeoxycytidylic acid; 2-Deoxy-5-hydroxymethylcytidine 5-phosphate

C10H16N3O8P (337.0674986)


   

2-Oxoclopidogrel

(2S)Methyl 2-(2-chlorophenyl)-2-(2-oxo-7,7a-dihydrothieno(3,2-c)pyridin-5(2H,4H,6H)-yl)acetate

C16H16ClNO3S (337.05393760000004)


2-Oxoclopidogrel is a thiolactone intermediate of clopidogrel, an antithrombotic prodrug (PMID: 23249383).. Hepatic cytochrome P450 (P450) enzymes catalyze the conversion of clopidogrel to 2-oxo-clopidogrel via CYP3A oxidation. After oxidation, 2-oxoclopidogrel is then subsequently hydrolyzed to the clopidogrel active metabolite known as CAM (PMID: 25970225). 2-oxoclopidogrel can form four isomers (H1, H2, H3 and H4) of CAM, in which H4 only found in humans. The H4 isomer exhibits twice the activity of the H2 isomer (PMID: 28602635). The H4 isomer blocks adenosine diphosphate (ADP) binding to the P2Y12 receptor which thereby inhibits ADP induced platelet aggregation. 2-oxoclopidogrel is only found in individuals that have used or taken Clopidogrel. Clopidogrel thiolactone is an important intermediate in the metabolism of clopidogrel (HY-15283). Clopidogrel thiolactone has antiplatelet aggregatione effects. Clopidogrel is a P2Y12 receptor inhibitor that exerts antiplatelet effects[1][2].

   

5-Carboxy-lumiracoxib

3-{[2-(carboxymethyl)-4-methylphenyl]amino}-4-chloro-2-fluorobenzoic acid

C16H13ClFNO4 (337.05171000000007)


5-Carboxy-lumiracoxib is a metabolite of lumiracoxib. Lumiracoxib is a COX-2 selective inhibitor non-steroidal anti-inflammatory drug, manufactured by Novartis and still sold in few countries, including Mexico, Ecuador and the Dominican Republic, under the trade name Prexige (sometimes misquoted as Prestige by the media). Lumiracoxib has several distinctive features. (Wikipedia)

   

1H-Imidazole-1-ethanol, 2-nitro-alpha-((2,2,2-trifluoro-1-(trifluoromethyl)ethoxy)methyl)-

1H-Imidazole-1-ethanol, 2-nitro-alpha-((2,2,2-trifluoro-1-(trifluoromethyl)ethoxy)methyl)-

C9H9F6N3O4 (337.04972260000005)


   

Glutathione peroxide

14-amino-9-(sulfanylmethyl)-1,2,3,4-tetraoxa-7,10-diazacyclopentadecane-5,8,11,15-tetrone

C10H15N3O8S (337.05798300000004)


   
   
   

2-methyl-5-oxo-4-(2-trifluoromethyl-phenyl)-5,7-dihydro-furo[3,4-b]pyridine-3-carboxylic acid

2-methyl-5-oxo-4-(2-trifluoromethyl-phenyl)-5,7-dihydro-furo[3,4-b]pyridine-3-carboxylic acid

C16H10F3NO4 (337.05618960000004)


   

2-Oxoclopidogrel

methyl (2S)-2-(2-chlorophenyl)-2-{2-oxo-2H,4H,5H,6H,7H,7aH-thieno[3,2-c]pyridin-5-yl}acetate

C16H16ClNO3S (337.05393760000004)


Clopidogrel thiolactone is an important intermediate in the metabolism of clopidogrel (HY-15283). Clopidogrel thiolactone has antiplatelet aggregatione effects. Clopidogrel is a P2Y12 receptor inhibitor that exerts antiplatelet effects[1][2].

   
   

ethyl 2-[(2-chloroacetyl)amino]-4-(4-methylphenyl)thiophene-3-carboxylate

ethyl 2-[(2-chloroacetyl)amino]-4-(4-methylphenyl)thiophene-3-carboxylate

C16H16ClNO3S (337.05393760000004)


   

5-Hydroxymethyl-2’-deoxycytidine

5-Hydroxymethyl-2’-deoxycytidine

C10H16N3O8P (337.0674986)


   

tert-butyl 1-(4-bromophenyl)-3-azabicyclo[3.1.0]hexane-3-carboxylate

tert-butyl 1-(4-bromophenyl)-3-azabicyclo[3.1.0]hexane-3-carboxylate

C16H20BrNO2 (337.06773200000003)


   
   

2-BENZOTHIAZOLYL-3-(4-CARBOXY-2-METHOXYPHENYL)-5-[4-(2-SULFOETHYLCARBAMOYL)PHENYL]-2H-TETRAZOLIUM

2-BENZOTHIAZOLYL-3-(4-CARBOXY-2-METHOXYPHENYL)-5-[4-(2-SULFOETHYLCARBAMOYL)PHENYL]-2H-TETRAZOLIUM

C10H16N3O6PS (337.0497406)


   
   
   

2-[3-(5-Mercapto-[1,3,4]thiadiazol-2-YL)-ureido]-N-methyl-3-phenyl-propionamide

2-[3-(5-Mercapto-[1,3,4]thiadiazol-2-YL)-ureido]-N-methyl-3-phenyl-propionamide

C13H15N5O2S2 (337.066713)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D061965 - Matrix Metalloproteinase Inhibitors

   

5-Methylcytidine 5-monophosphate

5-Methylcytidine 5-monophosphate

C10H16N3O8P (337.0674986)


   

2-O-methylcytidine 5-monophosphate

2-O-methylcytidine 5-monophosphate

C10H16N3O8P (337.0674986)


   

N-[4-(1-methylsulfonyl-2,3-dihydroindol-5-yl)-2-thiazolyl]acetamide

N-[4-(1-methylsulfonyl-2,3-dihydroindol-5-yl)-2-thiazolyl]acetamide

C14H15N3O3S2 (337.05548)


   

2-[[5-(2-Chlorophenyl)-1,3,4-oxadiazol-2-yl]thio]-1-(1-piperidinyl)ethanone

2-[[5-(2-Chlorophenyl)-1,3,4-oxadiazol-2-yl]thio]-1-(1-piperidinyl)ethanone

C15H16ClN3O2S (337.0651706)


   
   

N(3)-methylcytidine 5-monophosphate

N(3)-methylcytidine 5-monophosphate

C10H16N3O8P (337.0674986)


   

5-[2-[(4-chlorophenyl)thio]-1-oxoethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid methyl ester

5-[2-[(4-chlorophenyl)thio]-1-oxoethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid methyl ester

C16H16ClNO3S (337.05393760000004)


   

3-bromo-2-heptyl-1-hydroxy-4(1H)-quinolinone

3-bromo-2-heptyl-1-hydroxy-4(1H)-quinolinone

C16H20BrNO2 (337.06773200000003)


   

N(4)-methylcytidine 5-monophosphate

N(4)-methylcytidine 5-monophosphate

C10H16N3O8P (337.0674986)


   

(E)-4-(3-chlorophenyl)-2-oxo-3-quinolin-2-ylbut-3-enoic acid

(E)-4-(3-chlorophenyl)-2-oxo-3-quinolin-2-ylbut-3-enoic acid

C19H12ClNO3 (337.05056720000005)


   

5-Hydroxymethyldeoxycytidylic acid

5-Hydroxymethyldeoxycytidylic acid

C10H16N3O8P (337.0674986)


   

COR659

COR659

C16H16ClNO3S (337.05393760000004)


COR659 is a potent and effective GABAB positive allosteric modulator (PAM). COR659 suppresses alcohol and chocolate self-administration in rats[1].

   

5-{2h-[1,3]dioxolo[4,5-g]isoquinoline-5-carbonyl}-2h-1,3-benzodioxol-4-ol

5-{2h-[1,3]dioxolo[4,5-g]isoquinoline-5-carbonyl}-2h-1,3-benzodioxol-4-ol

C18H11NO6 (337.0586346)